Absolutely....it is now etting the attention it needs. The market is massive for this App. Once they get the childs pain App developed every parent with a smart phone will want this app. That is a market of hundreds of millions of people. This year the demential App will be the first to generate revenue and that will be followed by the children's App's next year. As EPT progresses down the path of FDA and TGA approval value will continue to come into the the stock. By third Qtr this year we should be approaching RAP levels of value and our market is bigger.
EPT Price at posting:
4.0¢ Sentiment: Buy Disclosure: Held
